Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease
Autor: | John L. Beard, James R. Connor, B. S. Snyder, E. J. Mufson, R. E. Fine |
---|---|
Rok vydání: | 1992 |
Předmět: |
Adult
Male Senescence Aging medicine.medical_specialty Pathology Iron Blotting Western Central nervous system White matter Cellular and Molecular Neuroscience Alzheimer Disease Internal medicine medicine Homeostasis Humans Aging brain Aged Aged 80 and over Brain Chemistry chemistry.chemical_classification biology Transferrin Human brain Middle Aged medicine.disease Ferritin medicine.anatomical_structure Endocrinology chemistry Ferritins biology.protein Female Alzheimer's disease |
Zdroj: | Journal of Neuroscience Research. 31:327-335 |
ISSN: | 1097-4547 0360-4012 |
Popis: | It is well established that iron, which is of considerable importance for normal neurological function, is highly regulated in all organ systems. However, until recently, iron regulation in the nervous system has received little attention. This study quantitatively compares the levels of the major iron-regulatory proteins, transferrin and ferritin, and iron itself in three cerebral cortical regions of the human brain from material collected at autopsy. Three groups were studied: 1) normal adult (under 65 yr of age), 2) aged (greater than 65), and 3) Alzheimer's disease. Normally, transferrin is more abundant in white matter than in gray matter. Ferritin is approximately 10x more abundant than transferrin throughout the brain regions examined and is evenly distributed, as is iron, in the gray and white matter. In Alzheimer's disease transferrin is consistently decreased particularly in the white matter of the various cerebral cortical regions examined whereas the iron and ferritin changes are inconsistent. The observations in this study are consistent with our general hypothesis that iron homeostasis is disrupted in the aging brain and the alterations in iron-regulatory proteins are exacerbated in Alzheimer's disease. The decrease in transferrin levels could indicate a decreased mobility and subsequent utilization of iron in the brain. Such a decrease in iron availability could play a significant role in neuronal degeneration and increased peroxidative damage known to occur in Alzheimer's disease. |
Databáze: | OpenAIRE |
Externí odkaz: |